{"id":"W2564551262","doi":"10.3999/jscpt.42.305","title":"2. Pharmacokinetics and Drug Interaction of New Anticoagulants: Direct Thrombin Inhibitor and Factor Xa Inhibitors","year":2011,"lang":"en","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Warfarin; Atrial fibrillation; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Stroke (engine); Anticoagulant; Drug; Pharmacokinetics; Pharmacology; Intensive care medicine; Internal medicine; Thrombin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004251603,0.00069127,0.001096566,0.001076161,0.0002284627,0.0008695116,0.0004162097,0.0007294085,0.003155597],"category_scores_gemma":[0.0005530213,0.0002250875,0.0009301383,0.0009780243,0.0001848991,0.0006810877,0.0003006963,0.0008862431,0.001237526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003697331,"about_ca_system_score_gemma":0.0008193275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001314803,"about_ca_topic_score_gemma":0.001330742,"domain_scores_codex":[0.9995623,0.00007408221,0.00007747286,0.00005832853,0.0001924929,0.00003538424],"domain_scores_gemma":[0.9997482,0.00007401936,0.00006676686,0.000007556896,0.00009104362,0.00001249328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004462451,0.0002922991,0.003859995,0.02011636,0.0004000508,0.001650194,0.0001702569,0.001291869,0.0182434,0.002736927,0.03495719,0.9158353],"study_design_scores_gemma":[0.0001074511,0.001074776,0.01675184,0.002466287,0.0008721158,0.01679537,0.0001241579,0.00140485,0.0118128,0.00182336,0.9466825,0.00008455726],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005557261,0.9852074,0.001615332,0.0009710357,0.0004273293,0.00004515785,0.0002581451,0.00005562128,0.005862711],"genre_scores_gemma":[0.02609892,0.9612691,0.002248107,0.001069738,0.0009502561,0.00008625242,0.0005112205,0.00001422311,0.007752241],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003155597,"threshold_uncertainty_score":0.01055652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1956427213105497,"score_gpt":0.4511079199138366,"score_spread":0.255465198603287,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}